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EDITORIAL—SYNTHETIC BIOLOGY
Synthetic biology builds upon over 35 years of genetic engineering. For example, in the 1970s methods were invented for
using enzymes to rework DNA. Applying these tools, bacteria were engineered to yield relevant products such as growth
hormones and insulin. Although many pioneering engineers were involved in such work, still more missed this biotech-
nology revolution or did not consider genetic engineering ‘real engineering’. This framing began to change in the late
1990s as the early genome projects neared completion. With several organisms sequenced and so-called ‘parts lists’ of
natural genetic components growing exponentially, the biological sciences community became pressed to develop better
methods for understanding how genes and proteins comprise healthy cellular systems, and how diseases arise in response
to underlying molecular changes. Many engineers, often trained to deal with complex systems, saw a new opportunity
to join in biological research at the cellular and molecular levels.
But some who entered were taken aback at the complexity of natural biomolecular systems. Luckily, a few researchers
learned enough molecular biology to realize that instead of directly grappling with nature’s inherent complexity, simpler
synthetic gene ‘circuits’ could be manually crafted using the tools of genetic engineering. For example, genetic analogs of
basic electronic circuits were engineered and natural organisms slightly rewired, with an optimism and excitement similar
to tinkering with a radio and with a resultant building of conﬁdence and framing of new scientiﬁc questions.
However, a new set of frustrations emerged as the pace, cost, and uncertainty of working with biology became apparent
to engineers more familiar with advanced systems engineering approaches based on electronic design automation and
rapid prototyping. Thus, some researchers began to explore if and how to make the entire process of engineering biology
easier. Under the label ‘synthetic biology’, we can now recognize a vibrant and sustaining research community working to
improve the process of engineering biology, in addition to producing speciﬁc biotechnology products. Importantly, rather
than separating science from engineering, the needs of the tool builders and the new questions posed by the early
‘tinkerers’ have created and ampliﬁed opportunities at the intersections of chemistry, physics, biology and engineering.
As one prominent example, direct chemical synthesis has become a practical alternative to cut-and-paste methods for
constructing large DNA molecules that encode entire biochemical pathways, or other functional genetic modules. This
approach has the beneﬁt of allowing complete ﬂexibility of design, with no requirements for placement of restriction sites
or other features that are not critical to the ultimate biological function of the designed sequence. Methods for seamless
assembly of synthetic DNA have enabled the complete synthesis of viral genomes and even a small bacterial genome.
Recently much progress has been made in our ability to manipulate and clone large pieces of DNA, both natural and
synthetic. For example, small bacterial genomes can be cloned in yeast, and then transferred back into a bacterial cell
where they ‘boot-up’ to direct the activities of the cell. These methods for synthesis and engineering, at the gene and
genome scale, have the potential to provide new insights into fundamental biological problems, such as deﬁning
the minimal genetic requirements for cellular life, while also allowing a subset of engineers to specialize in the design
of genetic systems.
For historical context, in the 19th century, chemists moved from describing the composition and structures of the
molecules with which they worked to synthesizing known compounds and inventing new ones. The resulting work led to
new scientiﬁc discoveries and many new chemicals, materials, and industries. We believe that the sciences of genetics and
molecular cell biology have now ﬁrmly entered their synthetic era. In addition to describing the physiology and behavior
of organisms, to determining the genetic sequences and identifying the molecules that make life work, biologists are now
able to learn by building, to discover by construction what is needed for life to work, and to explore what might evolve
next or be made anew. This is obviously an exciting time to be a biologist or biological engineer, as new discoveries pour
in and the next steps are taken to engineer organisms that contribute to human ﬂourishing and diverse, sustaining
environments.
As a journal, Nucleic Acids Research has constantly been at the forefront of innovative publishing practices relevant to
the genetic material and information. We were the ﬁrst to encourage computational biology papers, to require the
deposition of sequences in the GenBank/EMBL/DDBJ database, to devote special issues to Databases and Web
Servers and among the ﬁrst to move from a traditional subscription-based journal to a truly open access one.
Recognizing the importance of synthetic nucleic acid sequences and the further ramiﬁcations of those sequences, the
Journal is moving beyond mere description. We intend to provide a useful and innovative forum for publishing advances
in the dynamic area of synthetic biology. On an ongoing basis, we welcome your suggestions for what the ﬁeld needs from
a research journal, as well your manuscripts contributing to this exciting frontier at the conﬂuence of biology and
technology.
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